Stangeland; Eric L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stangeland; Eric L..The latest application filed is for "4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds".

Company Profile

0.66.58

Stangeland; Eric L. - Pacifica CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20220087995 - Patterson; Lori Jean ; et al.	2022-03-24
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,946,007 - Patterson , et al. March 16, 2	2021-03-16
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20200316048 - Patterson; Lori Jean ; et al.	2020-10-08
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,722,504 - Patterson , et al.	2020-07-28
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20200000792 - Patterson; Lori Jean ; et al.	2020-01-02
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,441,579 - Patterson , et al. Oc	2019-10-15
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20190134019 - Patterson; Lori Jean ; et al.	2019-05-09
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,206,913 - Patterson , et al. Feb	2019-02-19
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity Grant 10,138,220 - Hughes , et al. Nov	2018-11-27
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20180289687 - Patterson; Lori Jean ; et al.	2018-10-11
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,034,870 - Patterson , et al. July 31, 2	2018-07-31
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Grant 9,975,875 - Hughes , et al. May 22, 2	2018-05-22
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20180050024 - Patterson; Lori Jean ; et al.	2018-02-22
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170362200 - HUGHES; Adam D. ; et al.	2017-12-21
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,771,350 - Hughes , et al. September 26, 2	2017-09-26
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170226082 - HUGHES; Adam D. ; et al.	2017-08-10
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,682,957 - Hughes , et al. June 20, 2	2017-06-20
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 9,675,599 - Patterson , et al. June 13, 2	2017-06-13
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20170096412 - HUGHES; Adam D. ; et al.	2017-04-06
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,572,802 - Hughes , et al. February 21, 2	2017-02-21
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20160361304 - HUGHES; Adam D. ; et al.	2016-12-15
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20160184288 - Patterson; Lori Jean ; et al.	2016-06-30
Inhibitors of hepatitic C virus Grant 9,260,414 - McKinnell , et al. February 16, 2	2016-02-16
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 9,187,423 - Stangeland , et al. November 17, 2	2015-11-17
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds Grant 9,162,982 - Patterson , et al. October 20, 2	2015-10-20
1-(2-phenoxymethylphenyl)piperazine compounds Grant 9,012,460 - Stangeland , et al. April 21, 2	2015-04-21
Serotonin reuptake inhibitors Grant 9,000,191 - Stangeland , et al. April 7, 2	2015-04-07
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 9,000,173 - Hughes , et al. April 7, 2	2015-04-07
Novel Inhibitors Of Hepatitic C Virus App 20150071878 - McKinnell; Robert Murray ; et al.	2015-03-12
3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 8,933,249 - Stangeland , et al. January 13, 2	2015-01-13
Inhibitors of hepatitis C virus Grant 8,921,372 - McKinnell , et al. December 30, 2	2014-12-30
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140323733 - Hughes; Adam D. ; et al.	2014-10-30
Process For Preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20140323735 - Stangeland; Eric L. ; et al.	2014-10-30
3-phenoxymethylpyrrolidine compounds Grant 8,853,255 - Stangeland , et al. October 7, 2	2014-10-07
1-(2-phenoxymethylphenyl)piperazine Compounds App 20140288089 - Stangeland; Eric L. ; et al.	2014-09-25
Serotonin Reuptake Inhibitors App 20140243536 - Stangeland; Eric L. ; et al.	2014-08-28
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 8,816,088 - Hughes , et al. August 26, 2	2014-08-26
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,802,857 - Stangeland , et al. August 12, 2	2014-08-12
1-(2-phenoxymethylphenyl)piperazine compounds Grant 8,778,949 - Stangeland , et al. July 15, 2	2014-07-15
Serotonin reuptake inhibitors Grant 8,729,119 - Stangeland , et al. May 20, 2	2014-05-20
4-[2-(2-fluorophenoxy Methyl)phenyl]piperidine Compounds App 20140057944 - Patterson; Lori Jean ; et al.	2014-02-27
Serotonin reuptake inhibitors Grant 8,637,568 - Stangeland , et al. January 28, 2	2014-01-28
Biphenyl derivatives Grant 8,618,131 - Mammen , et al. December 31, 2	2013-12-31
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130331364 - Hughes; Adam D. ; et al.	2013-12-12
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,604,058 - Patterson , et al. December 10, 2	2013-12-10
1-(2-phenoxymethylheteroaryl) Piperidine And Piperazine Compounds App 20130324550 - Stangeland; Eric L. ; et al.	2013-12-05
Serotonin Reuptake Inhibitors App 20130296322 - Stangeland; Eric L. ; et al.	2013-11-07
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 8,551,978 - Hughes , et al. October 8, 2	2013-10-08
Serotonin Reuptake Inhibitors App 20130253013 - Stangeland; Eric L. ; et al.	2013-09-26
3-phenoxymethylpyrrolidine Compounds App 20130237581 - Stangeland; Eric L. ; et al.	2013-09-12
1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds Grant 8,530,663 - Stangeland , et al. September 10, 2	2013-09-10
Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,501,776 - Ji , et al. August 6, 2	2013-08-06
Serotonin reuptake inhibitors Grant 8,501,964 - Stangeland , et al. August 6, 2	2013-08-06
Serotonin reuptake inhibitors Grant 8,471,040 - Stangeland , et al. June 25, 2	2013-06-25
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130137665 - Hughes; Adam ; et al.	2013-05-30
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20130030020 - Patterson; Lori Jean ; et al.	2013-01-31
Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,329,911 - Mu , et al. December 11, 2	2012-12-11
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,304,432 - Patterson , et al. November 6, 2	2012-11-06
Process For Preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20120277438 - Stangeland; Eric L. ; et al.	2012-11-01
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,247,433 - Stangeland , et al. August 21, 2	2012-08-21
3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 8,242,164 - Stangeland , et al. August 14, 2	2012-08-14
Serotonin Reuptake Inhibitors App 20120142689 - STANGELAND; Eric L. ; et al.	2012-06-07
Novel Inhibitors Of Hepatitis C Virus App 20120114600 - McKINNELL; Robert Murray ; et al.	2012-05-10
Serotonin Reuptake Inhibitors App 20120088799 - STANGELAND; Eric L. ; et al.	2012-04-12
Diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity Grant 8,138,345 - Hughes , et al. March 20, 2	2012-03-20
Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,067,439 - Mammen , et al. November 29, 2	2011-11-29
1-(2-phenoxymethylheteroaryl)piperidine And Piperazine Compounds App 20110230495 - Stangeland; Eric L. ; et al.	2011-09-22
1-(2-phenoxymethylphenyl)piperazine Compounds App 20110172246 - Stangeland; Eric L. ; et al.	2011-07-14
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20110071190 - JI; Yu-Hua ; et al.	2011-03-24
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20110059931 - MAMMEN; Mathai ; et al.	2011-03-10
3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 7,888,386 - Stangeland , et al. February 15, 2	2011-02-15
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,868,175 - Ji , et al. January 11, 2	2011-01-11
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,851,631 - Mammen , et al. December 14, 2	2010-12-14
Diamide Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20100273755 - Hughes; Adam ; et al.	2010-10-28
3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, And 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl Compounds App 20100267743 - Stangeland; Eric L. ; et al.	2010-10-21
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20100137325 - Ji; Yu-Hua ; et al.	2010-06-03
Process For Preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20100125141 - Stangeland; Eric L. ; et al.	2010-05-20
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20100125092 - Patterson; Lori Jean ; et al.	2010-05-20
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,683,173 - Ji , et al. March 23, 2	2010-03-23
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20100063096 - Mu; YongQi ; et al.	2010-03-11
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20100041701 - Ji; Yu-Hua ; et al.	2010-02-18
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,642,355 - Mu , et al. January 5, 2	2010-01-05
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,629,336 - Ji , et al. December 8, 2	2009-12-08
Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20090076026 - JI; Yu-Hua ; et al.	2009-03-19
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,479,562 - Ji , et al. January 20, 2	2009-01-20
Biphenyl compounds useful as muscarinic receptor antagonists App 20070293461 - Mammen; Mathai ; et al.	2007-12-20
Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,262,205 - Mammen , et al. August 28, 2	2007-08-28
Biphenyl compounds useful as muscarinic receptor antagonists App 20060205946 - Ji; Yu-Hua ; et al.	2006-09-14
Biphenyl compounds useful as muscarinic receptor antagonists App 20060205775 - Ji; Yu-Hua ; et al.	2006-09-14
Biphenyl compounds useful as muscarinic receptor antagonists App 20060205779 - Mu; YongQi ; et al.	2006-09-14
Biphenyl compounds useful as muscarinic receptor antagonists App 20050203131 - Mammen, Mathai ; et al.	2005-09-15